Heron Therapeutics, Inc.
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a …
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$37,879
d
cs
10% Holder
|
11/04/24 |
A
|
37,879 x $0 = $0 |
Footnotes
#1 The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (11/4/2024).
#2 Each restricted stock unit represents a contingent right to receive one share of common stock.
|
|||
|
$103,123
d
cs
10% Holder
|
10/19/24 |
M
|
3,874 x $0 = $0 |
Footnotes
#1 Each restricted stock unit represents a contingent right to receive one share of common stock.
|
|||
|
$108,001
d
cs
10% Holder
|
10/19/24 |
M
|
3,874 x $0 = $0 |
Footnotes
#1 Each restricted stock unit represents a contingent right to receive one share of common stock.
|
|||
|
$290,387
d
cs
10% Holder
|
10/19/24 |
M
|
13,797 x $0 = $0 |
Footnotes
#1 Each restricted stock unit represents a contingent right to receive one share of common stock.
|
|||
|
$276,590
d
cs
10% Holder
|
07/19/24 |
M
|
13,797 x $0 = $0 |
Footnotes
#1 Each restricted stock unit represents a contingent right to receive one share of common stock.
|
|||
Get PRO Today
With PRO you will unlock 48 more insider transactions for Heron Therapeutics, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Christian Waage Director
- Collard Craig A Chief Executive Officer
- Dissanaike Sharmila Director
- Duarte Ira EVP, Chief Financial Officer
- Forbes William P EVP, Chief Development Officer
- Johnson Craig A Director
- Kaseta Michael Director
- Kotler Kevin Director
- Manhard Kimberly EVP, Drug Development
- Morgan Adam Director
- Peraza Lisa VP, Chief Accounting Officer
- Poyhonen John President & CCO
- Rodriguez Susan Director
- Szekeres David Leslie EVP, Chief Operating Officer
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Christian Waage Director
- Collard Craig A Chief Executive Officer
- Dissanaike Sharmila Director
- Duarte Ira EVP, Chief Financial Officer
- Forbes William P EVP, Chief Development Officer
- Johnson Craig A Director
- Kaseta Michael Director
- Kotler Kevin Director
- Manhard Kimberly EVP, Drug Development
- Morgan Adam Director
- Peraza Lisa VP, Chief Accounting Officer
- Poyhonen John President & CCO
- Rodriguez Susan Director
- Szekeres David Leslie EVP, Chief Operating Officer